THER-34. MEK BLOCKADE SYNERGISTICALLY INCREASES THE ANTI-TUMOR EFFECTS OF mTOR INHIBITION IN GLIOMAS

Abnormal signaling of the RAS/RAF and mTOR pathways predominates in pediatric low-grade gliomas (PLGGs). MLN0128 is a second-generation pan-mTOR inhibitor (TORC1/2). Rapalink-1, a third-generation bivalent mTOR inhibitor that combines rapamycin with MLN0128 by an inert chemical linker, shows potent...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neuro Oncol
Main Authors: Zhang, Jie, Liu, Kevin, Dik, Rogier, Yang, Xiaodong, Waanders, Angela, Resnick, Adam, Wright, Karen, Weiss, William, Haas-Kogan, Daphne, Mueller, Sabine
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2019
Assuntos:
Translational Therapeutics
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6477411/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz036.238
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados